(S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfon yl-2-methyl-1,4-homopiperazine hydrochloride dihydrate

Details for Australian Patent Application No. 2005308060 (hide)

Owner Kowa Co., Ltd. D. Western Therapeutics Institute, Inc.

Inventors Ohshima, Takeshi; Shiratsuchi, Masami; Onogi, Kazuhiro; Hidaka, Hiroyoshi; Oda, Toshiaki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005308060

PCT Pub. Number WO2006/057397

Priority 2004-344271 29.11.04 JP

Filing date 29 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 17 February 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057397 Priority application(s): WO2006/057397

17 February 2011 Application Accepted

  Published as AU-B-2005308060

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005308064-Intestine anastomosis assisting tool

2005308023-L-amino acid-producing bacterium and a method for producing L-amino acid